The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

That’s thanks to a major philanthropic commitment from Sarasota’s Brian and Sheila Jellison Family Foundation. As the first ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

This guest essay reflects the views of Dr. Richard Barakat, physician-in-chief at the Northwell Health Cancer Institute.

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

While January is Cervical Cancer Awareness Month, health experts say getting screened when necessary is important year-round.

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

Almost every one of us has either been diagnosed ourselves or had a relative diagnosed with cancer. I’ve been lucky enough to stay cancer free, but I’ve had several people close to me ...